Complications of endoscopic stenting in patients with esophageal cancer

2021 ◽  
Vol 15 (10) ◽  
pp. 14-19
Author(s):  
Həcər Nazim qızı Həsənova ◽  

Tədqiqat işində qida borusunun xərçəngi xəstələrində yaranan mənfəz daralmaların aradan qaldırılmasında özüaçılan metalik stentlərlə endoskopik stentləşmə üsulu zamanı baş verən erkən və gecikmiş ağırlaşmalar təhlil edilmiş və onların korreksiya üsulları təqdim edilmişdir. Tədqiqata 2017-2018-ci illər ərzində Milli Onkologiya Mərkəzinin endoskopiya şöbəsində müayinə və müalicə alan 44 nəfər stenozla müşayiət olunan qida borusunun xərçəngi xəstələri daxil edilmişdir. Stendləşmənin icrası zamanı ağırlaşmlara 4 xəstədə (9,1%), müdaxilədən sonra erkən ağırlaşmalar 10 xəstədə (22,7%), gecikmiş ağırlaşmalar isə 5 xəstədə (11,4%) qeydə alınmışdır. Bu zaman xəstələrə restentləşmə aparılmışdır. Nəticə. Özüaçılan metalik stentlərlə endoskopik stentləşmə - qida borusunun keçməməzliyini aradan qaldıran və minimal ağırlaşmalarla müşahidə olunan az invaziv üsuldur. Açar sözlər: qida borusunun xərçəngi, özüaçılan metallik stentlər, erkən və geçikmiş ağırlaşmalar

2020 ◽  
Vol 7 (2) ◽  
pp. 85-88
Author(s):  
V. Boyko ◽  
I. Belozerov ◽  
O. Kudrevich ◽  
Ye. Novikov ◽  
S. Savvi ◽  
...  

Abstract ENDOSCOPIC TREATMENT OF ESOPHAGEAL ANASTOMOTIC STENOSЕS AND LEAKAGES Boyko V., Belozerov I., Kudrevich O., Novikov Y., Savvi S., Makarov V., Hroma V., Sаrian I., Korolevska A., Bytyak S., Zhidetskyi V. Endoscopic stenting of esophageal anastomosis due to anastomotic stenosis or leakage is increasingly being used as one of the most effective, minimally invasive and safe methods of treatment. Materials and methods. This research is based on the experience of treatment of 49 patients with gastric and esophageal cancer who previously were operated at the clinic and had complications such as esophageal anastomotic leakage and stenosis. Anastomotic leakage was observed in 21 cases: 9 patients were with gastroesophageal anastomosis, 12 patients were with esophagointestinal anastomosis. Stenosis of esophageal anastomosis were observed in 38 cases: 20 patients were with gastroesophageal anastomosis, 18 patients were with esophagointestinal anastomosis. Results. All patients were undergone endoscopic stenting of esophageal anastomosis. The results of using this method of treatment were estimated. Conclusions. Stenting of the esophagеal anastomosis by coated self-expanding stents is a method of choice in the treatment of patients with esophageal anastomotic leakage and stenosis. Key words: gastrectomy, subtotal proximal gastrectomy, esophageal resection, anastomotic leakage, anastomotic stenosis, stenting of esophageal anastomosis.   Резюме. ЕНДОСКОПІЧНЕ ЛІКУВАННЯ СТЕНОЗУ І НЕСПРОМОЖНОСТІ СТРАВОХІДНОГО АНАСТОМОЗУ Бойко В.В., Бєлозьоров І.В., Кудревич О.М., Новіков Є.А., Савви С.О., Макаров В.В., Грома В.Г., Саріан І.В., Королевська А.Ю, Битяк С.Ю., Жидецький В.В. Ендоскопічне стентування стравохідних анастомозів внаслідок стенозу або неспроможності анастомозу все частіше використовується як один з найбільш ефективних, мініінвазивних і безпечних методів лікування. Матеріали та методи. Дане дослідження засноване на досвіді лікування 49 пацієнтів з раком шлунка і стравоходу, які раніше були прооперовані в клініці і мали такі ускладнення, як стеноз або неспроможність анастомозу стравоходу. Неспроможність анастомозу спостерігалася в 21 випадку: 9 пацієнтів з гастроезофагеальним анастомозом, 12 пацієнтів із стравохідно-кишковим анастомозом. Стенози стравохідного анастомозу спостерігалися в 38 випадках: 20 пацієнтів були з гастроезофагеальним анастомозом, 18 пацієнтів були з стравохідно-кишковим анастомозом. Результати. Всім пацієнтам було проведено ендоскопічне стентування стравохідного анастомозу. Результати використання цього методу лікування були оцінені. Висновки. Стентування стравохідних анастомозів покритими саморозширювальними стентами є методом вибору при лікуванні пацієнтів з неспроможністю або стенозом стравохідного анастомозу. Ключові слова: гастректомія, субтотальна проксимальна гастректомія, резекція стравоходу, неспроможність анастомозу, стеноз анастомозу, стентування стравохідного анастомозу.   Резюме. ЭНДОСКОПИЧЕСКОЕ ЛЕЧЕНИЕ СТЕНОЗОВ И НЕСОСТОЯТЕЛЬНОСТЕЙ ПИЩЕВОДНЫХ АНАСТОМОЗОВ Бойко В.В., Белозеров И.В., Кудревич А.Н., Новиков Е.А., Савви С.А., Макаров В.В., Грома В.Г., Сариан И.В., Королевская А.Ю, Битяк С.Ю., Жидецкий В.В. Эндоскопическое стентирование пищеводных анастомозов вследствие стеноза или несостоятельности анастомоза все чаще используется как один из наиболее эффективных, миниинвазивных и безопасных методов лечения. Материалы и методы. Данное исследование основано на опыте лечения 49 пациентов с раком желудка и пищевода, которые ранее были прооперированы в клинике и имели такие осложнения, как стеноз или несостоятельность анастомоза пищевода. Несостоятельность анастомоза наблюдалась в 21 случае: 9 пациентов с гастроэзофагеальным анастомозом, 12 пациентов с пищеводно-кишечным анастомозом. Стенозы пищеводного анастомоза наблюдались в 38 случаях: 20 пациентов были с гастроэзофагеальным анастомозом, 18 пациентов были с пищеводно-кишечным анастомозом. Результаты. Всем пациентам было проведено эндоскопическое стентирование пищеводного анастомоза. Результаты использования этого метода лечения были оценены. Выводы. Стентирование пищеводных анастомозов покрытыми саморасширяющимися стентами является методом выбора при лечении пациентов с несостоятельностью или стенозом пищеводного анастомоза. Ключевые слова: гастрэктомия, субтотальная проксимальная гастрэктомия, резекция пищевода, несостоятельность анастомоза, стеноз анастомоза, стентирование пищеводного анастомоза.


2008 ◽  
Vol 74 (12) ◽  
pp. 1215-1217
Author(s):  
Jonathan M. Hernandez ◽  
James S. Barthel ◽  
Scott T. Kelley

Iatrogenic esophageal perforation during endoscopy in the setting of malignancy is an uncommon but often devastating complication and presents a formidable challenge to the surgeon. We sought to determine the efficacy of a self-expanding plastic stent for esophageal perforation before neoadjuvant chemoradiation in a single patient. A 74-year-old woman with a T4N0 adenocarcinoma at the gastroesophageal junction was perforated during upper endoscopy. We elected to manage the perforation with a silicone-covered, self-expanding Polyflex® stent. Subsequent studies revealed good positioning of the stent with exclusion of the perforation from the esophageal lumen. The patient subsequently underwent neoadjuvant chemoradiation therapy with cisplatin, 5-flourouracil, and external beam radiation (2640 Gy) followed by minimally invasive, hand-assisted transhiatal esophagogastrectomy. We describe the first case of endoscopic stenting for locally advanced, perforated esophageal cancer for the purposes of administering neoadjuvant chemoradiation as a bridge to definitive surgery. This patient was able to resume oral nutrition after stenting and during neoadjuvant therapy, experiencing no major complications from chemoradiation. Chemoradiation does not necessarily preclude the use of endoscopically placed covered plastic esophageal stents as a bridge to resection, even in the face of iatrogenic perforation.


2018 ◽  
Vol 47 (2) ◽  
pp. 1025-1029
Author(s):  
Carolina Mann ◽  
Edin Hadzijusufovic ◽  
Hauke Lang ◽  
Peter P. Grimminger

We report a case of a 69-year-old patient with esophageal cancer and severe upper gastrointestinal bleeding during neoadjuvant radiochemotherapy who required mass transfusion followed by complex emergency procedures. Despite endoscopic stenting, the bleeding recurred, and thus emergency open surgery was required. Gastric wedge resection of the minor curvature necessitated by perforation caused by the endoscopic stent maneuver and duodenotomy with ligation of the gastroduodenal artery, as the cause of persistent intraluminal bleeding, were performed. The already prepared gastric conduit during the emergency operation did not become ischemic, even though the gastroduodenal artery, left gastric artery, and short gastric arteries were ligated during emergency surgery. After 2 months of recovery, a computed tomographic scan showed collateral perfusion of the conduit via the superior mesenteric artery. Therefore, a fully robotic (abdominal and thoracic) esophagectomy with pull-up of the gastric conduit was performed, with no post-surgical complications. The patient was discharged 10 days after the robotic esophagectomy. Six months after esophagectomy, the patient is in a good condition.


2021 ◽  
Vol 55 (3) ◽  
pp. 180-190
Author(s):  
Yu.M. Stepanov ◽  
O.M. Babii ◽  
B.F. Shevchenko ◽  
S.O. Tarabarov

Background. The purpose of the work was to evaluate the effectiveness of the endoscopic stenting method in stenosing cancer and strictures of the digestive tract. Materials and methods. Since January 2015, endoscopic stenting has been performed in 12 patients using self-expanding nitinol stents with/without polymer coating manufactured by Boston Scientific, Ltd (USA) and uncoated nitinol stents manufactured by Garson (Korea). The study included 8 men (66.7 %) and 4 women (33.3 %) aged 51–80 years, (63.0 ± 4.2) years on average. Stenosing esophageal cancer was diagnosed in 5 patients, stenosing cancer of the gastric outlet — in 3, stenosing duodenal cancer — in one, esophageal stricture — in 3 people. In all patients, the indication for stenting was impaired patency of the digestive tract due to the underlying di-sease. Results. Nutrition was restored in all patients. In the group of stenosing esophageal cancer, the 30-day mortality rate was 20 %, the median survival rate was 9 months. Recurrence of dysphagia was diagnosed in one person, recanalization of the stent lumen was performed. In the group with stenosing cancer of the gastric outlet and duodenum, the 30-day mortality rate was 33.3 %, the median survival rate was 11 months. Impaired gastric emptying was detected in one patient, repeated stent-to-stent stenting was performed. In the group with esophageal stricture, one individual had stent migration, so the stent was repositioned. Conclusions. Endoscopic stenting with self-expanding nitinol stents in incu­rable patients with malignant stenoses of the esophagus, stomach, duodenum and in those with benign esophageal strictures is the surgery of choice, a safe and effective method that allows you to restore and continue natural nutrition and thereby improve the quality of life in incurable cases. Complications arising in the late period after stenting were found in 25 % of patients, and were corrected endoscopically.


2016 ◽  
Vol 1 (13) ◽  
pp. 169-176
Author(s):  
Lisa M. Evangelista ◽  
James L. Coyle

Esophageal cancer is the sixth leading cause of death from cancer worldwide. Esophageal resection is the mainstay treatment for cancers of the esophagus. While curative, surgical resection may result in swallowing difficulties that require intervention from speech-language pathologists (SLPs). Minimally invasive surgical procedures for esophageal resection have aimed to reduce morbidity and mortality associated with more invasive techniques. Both intra-operative and post-operative complications, regardless of the surgical approach, can result in dysphagia. This article will review the epidemiological impact of esophageal cancers, operative complications resulting in dysphagia, and clinical assessment and management of dysphagia pertinent to esophageal resection.


Sign in / Sign up

Export Citation Format

Share Document